Neuberger High Yield Strategies Fund Announces Increase in Leverage

High Yield Strategies Fund (NHS) approved a $25m increase in committed revolving debt capacity and plans to issue an additional $10m of Mandatory Redeemable Preferred Shares, Series D, likely within a week after documentation. Post-closing, the fund expects up to $135m of committed revolving financing and $50m of Series D preferred outstanding, increasing total leverage to better match its asset level following earlier transferable rights issuance. The move modestly raises leverage/capital structure risk, which may weigh slightly on sentiment.

Analysis

This is mostly a balance-sheet normalization event, not a fresh alpha signal. In stable credit conditions, incremental leverage in a levered high-yield vehicle is mechanically accretive to income, but only if asset yield stays comfortably above funding cost; that spread is the whole story. The more important second-order effect is that levered credit funds become forced marginal buyers of lower-quality paper, which can support CCC/BB spreads at the margin even when flow into the broader credit market is soft.

The risk profile is asymmetric. The same leverage that lifts current income also amplifies NAV drawdowns and can pressure distribution coverage quickly if credit spreads widen or short-term financing costs reset higher; that risk shows up in days-to-weeks, while the benefit is usually realized over months. The market’s likely mistake is reading this as a bullish signal on the portfolio when it may simply reflect post-rights-offering asset normalization and an attempt to re-lever back to target exposure.

Contrarian take: if the fund needed to expand leverage right after a rights offering, the underlying message may be that management is chasing carry in a market where the easy spread compression has already happened. That makes this more vulnerable to a late-cycle reversal than to a near-term rerating. The key falsifier is not the headline but whether the fund can maintain coverage and NAV stability through the next 1-2 credit spread selloffs.

Key Decisions for Investors

• No immediate trade in NBPVF; wait for the post-close discount/premium to NAV and next coverage report before acting.
• If NBPVF rallies on the financing news and trades richer to NAV, fade it via a short/underweight in levered credit CEFs over the next 1-3 months.
• Use HYG as the cleaner expression of credit beta: stay long HYG / avoid or short levered CEF exposure if HY spreads remain range-bound but volatility rises.
• Set an alert if HYG option-adjusted spreads widen by 50-75 bps or if financing costs rise further; that would be the trigger to cut levered credit exposure.
• If distribution coverage deteriorates in the next report, the thesis turns bearish quickly; that would be the point to consider a defensive pair trade against other high-yield CEFs.